1. Prostaglandin E1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular diseases in man
2. 2) Miyata T, Akagi D, Yamamoto K, Hosaka A, Miyahara T, Saito K, Kanetaka T, Nakazawa T, Okamoto H, Shige-matsu K, Koyama H, Shigematsu H, Nagawa H: From the standpoint of vascular surgery. Diabetic Complica-tions, 2004; 18:154-156 (in Japanese)
3. Amputation and Mortality in New-Onset Diabetic Foot Ulcers Stratified by Etiology
4. 4) Toyota T, Ikeda Y, Matsuoka K, Sakuma A: Clinical assessment of lipo PEG1 for diabetic neuropathy and skin ulcers: A multicenter, collaborative, double-blind, pla-cebo-controlled study. J Clin Exper Med, 1990; 155: 749-769 (in Japanese)
5. 5) Hirata Y, Ikeda Y, Matsuoka K, Tanaka T: Clinical assess-ment of the lipo PEG1 injection for diabetic neuropathy and skin ulcers/gangrenes: A multicenter controlled study using an existing PGE1 preparation, J Adult Dis, 1987; 17: 161-181 (in Japanese)